360 likes | 477 Views
Inventory of pathogenomics-related programmes *Ina Keutmann Project Management Jülich. WP2* Study on the programmes in third countries and existing international cooperations. Results Task 2.1. Who was included in the inquiry? Methodology Responses ERA-NET Partners/ Third Countries
E N D
Inventory of pathogenomics-related programmes *Ina Keutmann Project Management Jülich WP2*Study on the programmes in third countries and existing international cooperations
Results Task 2.1 • Who was included in the inquiry? • Methodology • Responses • ERA-NET Partners/ Third Countries • Results sorted by Categories of national funding • Transnational Funding/ Cooperations • Summary
Inquiry through questionnaire sent via E-mail 10 ERA-NET partner countries 21 Third European countries 16 Third countries outside Europe Investigation in and outside Europe Questionnaire was sent to approx. 150 contacts* in approx. 40 countries (Feedback rate 8%) *(ministries, foundations, national institutes, academies, EU contacts (Cordis)) • Additional Identification of programmes and contacts by • internet research • Collaboration of the International bureau, Bonn
Questionnaire was sent to ERA-NET Partners on December 8th ´04 • Questionnaire concerning (inter-)national programmes: • A1: General Programme Information • A2: History and Road Map of the Programme • A3: Programme / Project statistics • A4: Research Content • The ERA-NET Partners were kindly asked to send the completed questionnaire back until February 5th 2005 Answers from 4 Countries are still missing…
Countries included in this survey:+Programmes, Projects or Grants identified
(Genome-)Programmes that, among other topics, cover pathogenomic projects National programmes, with pathogenomic related programme parts and larger projects that are part of a more general funding programme 3. Grants and Funds that cover pathogenomics related projects Categories of national funding
Results (Genome-)Programmes that, among other topics, cover pathogenomic projects and larger projects as part of a more general funding programme e.g. Canada 1. Genome Canada 2. Genomics of Human Pathogens and their Host Interactions 3. Immunochemistry Program
Established by the federal government in April 2000 A not-for-profit corporation leading a national strategy on genomics and proteomics with $375 Mio in funding from the Government of Canada Dedicated to developing and implementing a national strategy in genomics and proteomics research Genome Canada has established 5 Genome Centres across the country 2 running programmes focused on human pathogens Genome Canada
1. Comparative and Functional Genomics of the Human Pathogen Cryptococcus neoformans Funding: Genome Canada (50%) Genome British Columbia (50%) Funding Envelope: total value : $ 2.158.557 (€ 1.322.040) Project goal: to identify the virulence mechanisms by which Cryptococcus causes disease inhumans Genome CanadaProjects
Genome wide Essential Gene Identification in Candida albicans and Applications to Antifungal Drug Discovery Funding: Genome Canada (50%) Genome Québec (50%) Funding Envelope: Total value: $ 5.740.927 (€ 3.516.114) Project Goal: to genetically dissect the organism to identify all essential genes to identify all drug targets Genome CanadaProjects
Funding: Provided by the Canadian Federal Government through the National Research Council (NRC) Duration of the programme: Original program (Genome Sciences in Infectious Diseases) 1999 to 2002 renewed in 2002 as the Genomics of Human Pathogens and their Host Interactions continued until March 2005 Funding Envelope: Budget from 1999 to 2005: $ 26 Mio (€ 15.924.077) Content: The objective was to apply new genomics tools to three human pathogens, Candida albicans, Francisella tularensis and Campylobacter jejuni. 8running projects focused on human pathogens 2. Canadian Programme: Genomics of Human Pathogens and their Host Interactions The programme is part of the Genomics and Health Initiative (GHI)
Funding Organization: Canadian federal Government Running since 1929, with changing of the current foci of the research Actually 2 running projects focused on human pathogens: 1. Project Title: Molecular Pathogenesis 2. Project Title: Pathogen Genomics Details see report 3. Canadian Programme: Immunochemistry Program
e.g. USA: Microbiology and Microbial Pathogenesis Programme Large Scale Genome Sequencing Program includes “Pathogen Genomics” (Genome-)Programmes that, among other topics, cover pathogenomic projects and larger projects as part of a more general funding programme
1. USA Programme:Microbiology and Microbial Pathogenesis Programme • Programme Owner: • The National Institute for Dental and Craniofacial Research (NIDCR) • (National Institute of Health, Department of Health and Human Services) • Sequencing support since 1995 • Funding Envelope: The goal is a success rate of 25% • (by the end of the fiscal year NIDCR will have funded 25% of the research grant applications assigned to the institute) • Actually 13 running sequencing projects focused on human pathogens
Programme Owner: National Institute of Allergy and Infectious Diseases NIAID/ National Institute of Dental and Craniofacial Diseases NIDCR Running since September 1999 An Addendum to this programme has been released in 2000 by the NIAID together with the Defence Advance Research Project Agency. This addendum complemented the “Large Scale Genome Sequencing Program” by focussing on pathogens as pathogen agents for bioterrorism. 40 running sequencing projects focused on human pathogens estimated 10 additional projects in the field of pathogenomics No detailed information was available in concerning the funding envelope 2. USA Programme: “Pathogen Genomics” within the “Large Scale Genome Sequencing Program”
Australia: Medical Bioinformatics, Genomics and Proteomics Programme China: Gene Manipulation Programme Germany: Infection and Inflammation Network Japan: National BioResource Project Pathogenic Microorganisms Research for the Future Programme Korea: 21st Century R&D Programme Malta: National RTDI Programme Romania: VIASAN – National programme of Biomedical research Sweden: Functional analysis of the vag-gen family-a constitute of conserved genes among bacterial pathogens Switzerland: Antibiotic Resistance Taiwan: National Research Programme for Genomic Medicine UK: Plant and Microbial Science Programme/ Agri-Food Programme Vietnam: National Programme on Biotechnology National programmes, with pathogenomic related programme parts and larger projects that are part of a more general funding programme e.g.:
Programme Owner: German Federal Ministry for Education and Research First Phase started 2001, actual programme runs from 2004 to 2007 Funding: 15.991.668 € for the whole network 6.539.584 € (14 microbial pathogens projects) Content: The Infection and Inflammation Network of the NGFN has assembled scientific and clinical investigators of different backgrounds and comprises 9 work packages; 3 WPs are concerned with human pathogenic bacteria WP 1 Sepsis WP 2 Gastrointestinal infections WP 5 Tuberculosis The objective is to develop functional and comparative studies, into a molecular understanding of the human inflammatory response system in health and disease, thereby improving diagnostic and therapeutic options. 14 running projects focused on human pathogens (49 in total ) GermanyInfection and Inflammation Network of the National Genome Research Network
Programme Owner: Swiss National Science Foundation Duration of the programme:1999–2006 Funding Envelope: CHF 12 million (7.763.473 €) over a 5- year period Content : - Scientific strategies of resistancemonitoring - Survey of the current resistance situation - Determination of the degree of mobility of resistant bacteria and genes - Molecular studies on bacterial resistance - Social, legal, ethical and economic aspects ~ 5-10 running projects focused on human pathogens (21 total) Switzerland “Antibiotic resistance” NRP49
Programme Owner: The Ministry of Education and Research (MEdC) Running from 2001-2006 Funding Envelope: About 2,7 million € for the projects in the Genomics and Proteomics field, including both clinical and fundamental research Content: The VIASAN Programme includes four thematic fields of research: Immunology & Organ Transplant, Neuroscience, Cellular and Molecular Medicine and Genomics and Proteomics. 63 running projects for Genomics and Proteomics field RomaniaThe National Programme of Bio-medical research and Development “Life and Health” (VIASAN)
Ireland: Science Foundation Ireland grants Israel: Israel Scientific Foundation grants U.K.: The Wellcome Trust New Zeeland: Marsden Fund grants Grants and Funds that cover pathogenomics related projects e.g.
United Kingdom Funding Organization: The Wellcome Trust (WT) 1. 1995 Set up of the Pathogen Sequencing Unit (PSU) to sequence the genomes of organisms relevant to human and animal health • PSU is now funded through the Sanger Institute • Main budget provided by the WT • Funding support of the Institute: 300 Mio £ (432 Mio € ) from 2001 to 2006
Funding Organization: The Wellcome Trust (WT) 2. Ad hoc applications are accepted in all areas of pathogen research e.g. Project grants: 3 year-project grant awards £150 000 to £300.000 (218.277 - 436.554 €) Programme grants: 5 year programme grant awards up to £1 200. 000 (1.746.217 €) United Kingdom
Europe Only one binational programme: MICMAN Partner countries: Finland – Sweden Organizations: Acadamy of Finland Swedish Foundation for Strategic Research (SSF) Duration of the programme: 01.01.2003 – 31.12.2005 Main objective: -to increase the understanding and knowledge of the interaction between host and microbes - to apply this knowledge to the maintenance of health and to prevention and treatment of diseases Transnational Funding
Funding Envelope (1/2003 – 12/2005): The total budget of the programme: 5,4 Mio € Academy of Finland: 4,1 Mio € Swedish Foundation for Strategic Research: 1,3 Mio € 15 research projects or consortia: 5 Finnish-Swedish consortia 2 Finnish consortia 8 individual Finnish projects. Altogether 26 research groups are funded in these projects/consortia MICMAN
Transnational FundingSpecial Programme for Research and Training in Tropical Diseases (TDR) • Global Collaborative research grant • “Pathogenesis and Applied Genomics” • TDR is an independent global programme of scientific collaboration • co-sponsored by • United Nations Children's Fund (UNICEF) • United Nations Development Programme (UNDP) • World Bank • World Health Organization (WHO) • TDR depends on voluntary contributions from donors for most of its income. • In 2004, contributing partners consisted of: • 4 co-sponsors • 23 governments • 9 other (foundations, agencies etc.) • Total Budget for 2004: US$ 6.614.992,00 (5.122.738 €)
Duration:Established in 1975 The aim is to help coordinate, support and influence global efforts to combat a portfolio of major diseases of the poor and disadvantaged TDR supported international efforts to unravel the genomes of tropical parasites through five genome networks. Funding Research projects: up to US$ 35 000 per year for 2 years one-time renewal possible (27.105 €) Multicentre projects: up to a total of US$ 70 000 per annum and for a 2 years (54.210 €) The project must involve endemic country researchers (South-South or South-North collaborations) Special Programme for Research and Training in Tropical Diseases (TDR)“Pathogenesis and Applied Genomics”
Finland/ MICMAN Sweden Norway: The national functional genomics research programme in Norway (FUGE) Cooperation with Norwegian and foreign research groups Ireland: The Health Research Boardworks closely with partners in Northern Ireland, the United States and Europe . Transnational Cooperations European results
Canada: Genomics of Human Pathogens and their Host Interactions formal collaborations with institutes and research groups in Europe and USA. The GHI Coordination Office considered this information confidential. - Immunochemistry Program “…international research collaborations are too numerous to list.“ Israel:German Israel foundation for Scientific Research and Development US Israel binational Science fund (BSF) Korea: “The 21st Century Frontier R&D Program” includes foreign collaboration due to the problem of the shortage of home-grown talents Vietnam: National Program on Biotechnology Cooperations with Japan, UK, Australia, Germany Transnational CooperationsResults Outside Europe
USAInternational Collaborations in Infectious Disease Research ProgramProjects in Cooperation with Universities of:
Pathogenomic related projects covered by unspecific programmes Obviously most focused countries outside Europe: Canada and USA Transnational pathogenomic activities on programme level are rare: In Europe only Finland and Sweden Most mentioned scientific contents have been questions on The host pathogen interaction The problem of resistance Genome sequencing for further applications Summary
Pathogenomic related projects covered by unspecific programmes Obviously most focused countries outside Europe: Canada and USA Transnational pathogenomic activities on programme level are rare: In Europe only Finland and Sweden Most mentioned scientific contents have been questions on The host pathogen interaction The problem of resistance Genome sequencing for further applications There is a big need for coordination activities! Summary
Thank you for your kind attention! Any Questions!
Programme Owner: Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Running from 2003-2008 No information on funding budget available Content: - research in infections and microorganisms - education of students in the control of infections - basic research for countermeasures against bioterrorism - providing of a systematic accumulation, storage and provision structure for nationally recognized bio resources ~ 24 central resource centres and an information centre are involved JapanNational BioRsource Project "Pathogenic Microorganisms (Bacteria, Fungi and Protozoa)“ Part of the "Research Revolution 2002 (RR2002)